Prognostic value of absent end-diastolic flow within the first week following renal transplantation

Transplant Proc. 2009 Mar;41(2):645-7. doi: 10.1016/j.transproceed.2008.12.006.

Abstract

Background: Doppler sonogram of the graft is used as a routine assessment in renal transplantation. When the resistance index (RI) equals 1, absent end-diastolic flow (AEDF) is observed; the prognostic value of AEDF is presently unknown.

Patients and methods: Between 1988 and 1996, 342 patients received a first cadaveric kidney transplant in our ward. AEDF was observed in 30 patients who were compared with 60 controls who showed an RI < 0.75 within the first 7 days after transplantation. They were matched for year of transplantation (+/-1 year); recipient age (+/-2 years); recipient sex; and HLA antibodies (3 classes: 0%, 1-75%, >75%). The follow-up was 4 years.

Results: AEDF was observed at day 1 in 64%, at day 3 in 96%, and at day 7 in 28%. Recipient age, donor age, recipient sex, cold and warm ischemia durations, HLA A, B, and DR mismatches, and cytomegalovirus (CMV) status were not different between the 2 groups. Immediate graft function and 3- to 24-month creatinine levels were better in the control than the AEDF group. However, there was no difference in serum creatinine at 3 and 4 years or in patient and graft survivals during follow-up.

Conclusions: AEDF observed within the first week following transplantation is associated with impaired renal functional recovery. However, whether AEDF is a prognostic marker of poor long-term graft function or survival remains to be proven.

MeSH terms

  • Adult
  • Cadaver
  • Creatinine / blood
  • Diastole / physiology*
  • Diuresis
  • Female
  • Follow-Up Studies
  • Graft Survival
  • Histocompatibility Testing
  • Humans
  • Kidney / diagnostic imaging
  • Kidney Transplantation / immunology
  • Kidney Transplantation / physiology*
  • Laser-Doppler Flowmetry / methods*
  • Male
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Time Factors
  • Tissue Donors
  • Treatment Outcome
  • Ultrasonography
  • Young Adult

Substances

  • Creatinine